Epithelial Stem Cell Fate Determines Chemoradiotherapy Response in Rectal Cancer
N. Li, Fiza Ishaqwala, Thomas A. Wright, Alistair Wilkinson, Petra Vlckova, Katherine E. Trevers, Rhianna O’Sullivan, Shauna Crampsie, Ewa Basiarz, Sierra Vanderkamp, A McCulloch, Aurélie Dobric, Smita Krishnaswamy, Bart Vanhaesebroeck, Campbell S.D. Roxburgh, , Christopher J. Tape
This study identifies that epithelial stem cell fate, not DNA damage, determines chemoradiotherapy response in rectal cancer by analyzing patient-derived organoids and using SPARTA to validate findings.
bioRxiv · Jul 15, 2026 · PreprintCancer Biology